Evidence map›Paper›PMID 40837455›Full record

ArticleClinical parkinsonism & related disorders2025

Advance care planning in Hispanic populations with Parkinson's Disease: Investigating disparities in end-of life care.

Taylor Peabody, Monica Abou-Ezzi, Lucila Hernandez, Henry Moore, Silvia Vargas-Parra, Alberto Cruz, Danielle S Shpiner

Abstract read
In one paragraph

Article in Clinical parkinsonism & related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Taylor PeabodyDepartment of Neurology, University of Miami Miller School of Medicine, 1150 NW 14 St #609, Miami, FL 33136, USA.
Monica Abou-EzziBoston University Chobanian and Avedisian School of Medicine72 East Concord St., Boston, MA 02118, USA.
Lucila HernandezDepartment of Neurology, University of Miami Miller School of Medicine, 1150 NW 14 St #609, Miami, FL 33136, USA.
Henry MooreDepartment of Neurology, University of Miami Miller School of Medicine, 1150 NW 14 St #609, Miami, FL 33136, USA.
Silvia Vargas-ParraDepartment of Neurology, University of Miami Miller School of Medicine, 1150 NW 14 St #609, Miami, FL 33136, USA.
Alberto CruzDepartment of Public Health Sciences, University of Miami Miller School of Medicine, 1120 NW 14th Street, CRB 919, Miami, FL 33136, USA.
Danielle S ShpinerDepartment of Neurology, University of Miami Miller School of Medicine, 1150 NW 14 St #609, Miami, FL 33136, USA.

Funding

Miami Clinical and Translational Science InstituteUM1TR004556 · NCATS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Olveen Carrasquillo, ERIN N KOBETZ · 2023 to 2026
$16.0M
NCATS NIH HHS UM1 TR004556
6 · The paper itself

Abstract

Introduction: Advance care planning (ACP) is a tool for optimizing end-of-life care and is an important aspect of healthcare for people with Parkinson's disease (PD). However, there may be disparities in access to ACP based on race and/or ethnicity. Methods: We conducted a cross-sectional survey of people with PD and care partners from a diverse academic Movement Disorders clinic regarding familiarity with ACP and sociodemographic factors. We compared prior experiences with ACP, with a primary outcome examining prior completion of healthcare power of attorney (HPOA) and advance directives (AD) among Hispanics and non-Hispanics in the cohort. Univariate analysis was utilized to compare cohort demographics. A multinomial logistic regression was performed to control for possible confounders. Results: 250 participants completed the survey, including 116 (46.4 %) who self-identified as Hispanic and 127 (50.8 %) non-Hispanic. Only 20 % of Hispanic participants had previously completed HPOA documentation versus 66.9 % non-Hispanics (p < 0.001). The rates of completion for AD were 6.1 % and 31.7 %, respectively (p < 0.001). Hispanic respondents were less likely to have heard about these documents and more likely to wait until later in the disease course to discuss ACP, despite a majority viewing these discussions as important. These trends remained when controlling for several demographic variables; however, age and preferred language of survey emerged as potential confounders for some answer choices. Conclusions: Hispanic people with PD may be less likely to utilize ACP than their non-Hispanic counterparts. Awareness of these resources or cultural factors may play a role and should be explored further in future studies.

Indexed as

Advance care planningEnd-of-life careHealthcare disparitiesParkinson’s disease

Identifiers

PMID40837455
PMCPMC12363598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.